Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Multi-Omics, Spatial & Data

PART OF Biomarkers, CDx & Precision Medicine US

23 - 24 September 2026 | Gaylord Pacific Resort & Convention Center, San Diego, CA

Programme Summary

The Multi-Omics, Spatial & Data programme picks up the molecule with the methods that now define it: spatial transcriptomics, multiplex imaging, single-cell spatial analysis, multi-omic integration, tumour microenvironment characterisation, and the bioinformatics layer that makes the data usable in precision oncology.

The Day 2 plenary on interpretable multi-omics for clinical decision-making anchors the programme, supported by three dedicated tracks across the two days. The wider event sits around it: cross-programme sessions throughout, with the integrated diagnostics panel bringing biomarkers, multi-omics and computational pathology together to look at how spatial and multi-omics data is reshaping the precision medicine pipeline end to end. 

Multi-Omics Top Image

Day 2 Plenary Keynote

PABLO TAMAYO, UCSD School of Medicine

Pablo Tamayo, Professor in the Division of Genomics and Precision Medicine at UCSD School of Medicine, opens Day 2 of Biomarkers, CDx & Precision Medicine US 2026 with the plenary on interpretable multi-omics at scale. His session presents the Celsus AI/ML Multi-Omics Framework: foundation-model approaches to multi-omics integration, interpretable machine learning for clinical translation, and how multi-omics data becomes usable for treatment decisions. 

Pablo Tamayo Headshot

2026 Highlights

The Multi-Omics, Spatial & Data programme covers the methods reshaping precision oncology in 2026. Spatial transcriptomics unlocks a host of archived samples, driving early detection and patient stratification. Multiplex imaging and single-cell spatial reveal tumour microenvironment biology at a resolution not previously seen before.

Track keynotes from Ming (Tommy) Tang (AstraZeneca) on multi-omics, ML and data integration methodology in drug development, and Alexander Klimowicz (Boehringer Ingelheim) on leveraging spatial biology and AI to strengthen understanding of the tumour microenvironment.

Plus sessions on multi-omic data integration, single-cell spatial workflows, AI-enabled tumour microenvironment analysis, and the bioinformatics infrastructure required to operate at scale. The cross-programme integrated diagnostics panel connects this work to the CDx and computational pathology programmes. 

Our Community and Culture Circle Image
NextGen Biomed - What to Expect Networking 4
600

leading pharma, biotech, regulatory & academic delegates

700
pre-arranged 1-2-1 meetings, facilitating business growth
50
hours of presentations, discussions & interactive content
12
hours of networking breaks, including fireside chats & refreshments

Multi-Omics, Spatial & Data Agenda at a Glance

DAY ONE

Track 4: Multimodal Bioinformatics, Data Analytics & Interpretation Track 5: Spatial Multi-Omics Techniques & Approaches

DAY TWO

Track 4: Applications of Spatial Research, Technologies & AI in Biology

BIOMEU On Page Agenda

Key Event Highlights

An unmissable journey awaits you: from celebrated keynote speakers and insightful private roundtables, to an exclusive gala dinner. Discover the moments that will transform your NextGen Omics & Spatial experience. 

Featured Speakers for Multi-Omics, Spatial & Data US 2026

Arvind Rao
Professor of Computational Medicine and Bioinformatics, Radiation Oncology,
University of Michigan
Carlo Bifulco
Chief Medical Officer ,
Providence
Chi-Ming Li
Scientific Associate Director,
Amgen Inc
Jianying Hu
IBM Fellow, Director, HCLS Research, Global Science Leader, AI for Healthcare,
IBM
Jordan Kardos
Head of Computational Biology,
Arda Therapeutics
Lana Garmire
Professor, Vice Chair of Research, Department of Biomedical Informatics & Data Science,
University of Alabama at Birmingham
Ming Tang
Director of Bioinformatics,
AstraZeneca
Stephanie Craig
Senior Lecturer in Precision Medicine,
Queen's University Belfast
Suhas Vasaikar
Associate Director,
Pfizer Ltd

Interested in Sponsoring Multi-Omics, Spatial & Data?

Become a driving force in accelerating the next generation of personalized treatments. Biomarkers, CDx & Precision Medicine US offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, & academic experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, & collaborate with the community shaping the future of precision medicine today.

Pre Med + LSX Combined Logo

Unlock the Latest News and Insights

Sign-up for our regular LifeScienceXchange newsletter to keep up to date with all things Precision Medicine, direct to your inbox.

Pre Med Newsletter Icon-1

Partner With Us

Position your spatial, multi-omics or data platform in front of the senior translational science audience working at the front of precision oncology. Sponsorship options include presentation slots, exhibition space, branded sessions and pre-arranged 1:1 meetings. 

Register Now

Spatial, multi-omics and translational data, in conversation with the wider precision medicine pipeline.
San Diego. 23 – 24 September 2026. 

Decision 1

Sentence describing Decision 1

Decision 2

Sentence describing Decision 2